Use of pkc inhibitors for the manufacture of a medicament...

Details Use of pkc inhibitors for the manufacture of a medicament... Use of pkc inhibitors for the manufacture of a medicament...

A - Human Necessities

61

K

A61K 31/40 (2006.01) A61K 31/00 (2006.01) A61K 31/395 (2006.01) A61K 31/407 (2006.01)

Patent

CA 2263161

A method for treating human T cell lymphotrophic virus type 1 infection using an isozyme selective PKC inhibitor, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,-N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N- dimethylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione hydrochloride salt.

Procédé de traitement concernant les infections de lymphocytes T provoquées par le virus du lymphome humain de type 1 (HTVL-1), particulièrement au moyen de l'inhibiteur de la protéine kinase C (PKC) à isoenzyme sélective, sel hydrochlorure de (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(0)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indolyl)]-(H)-pyrrole-2,5-dione.

Affiliated with

Also associated with

Rating

Use of pkc inhibitors for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pkc inhibitors for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pkc inhibitors for the manufacture of a medicament... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1951210